Top Markets
Coin of the day
PT Merck Tbk PT Merck Tbk

PT Merck Tbk

MERK
Rank in Stocks #21542
Operating in Indonesia, PT Merck Tbk is a pharmaceutical company focused on the... Operating in Indonesia, PT Merck Tbk is a pharmaceutical company focused on the production and distribution of medicinal products. Its business operations are structured into three main divisions: Biopharma, Consumer Health, and an 'Others' segment. The company provides healthcare solutions addressing a broad spectrum of therapeutic areas, including conditions related to the cardiovascular system, metabolism, oncology, endocrinology, fertility, and neurodegenerative disorders, alongside general pharmaceutical offerings. Furthermore, PT Merck Tbk is actively involved in the discovery, development, production, and commercialization of both pharmaceutical and biological prescription drugs. These medicines target specific conditions such as colorectal and head and neck cancers, multiple sclerosis, infertility, growth hormone imbalances, diabetes, and various thyroid conditions like hyperthyroidism and hypothyroidism. Beyond its core pharmaceutical activities, the company also engages in property leasing and management. Established in 1970 and headquartered in East Jakarta, Indonesia, the company was originally known as PT Merck Indonesia Tbk before adopting its current name, PT Merck Tbk, in June 2002. It operates as a subsidiary of Merck Holding GmbH.
Share Price
$0.23475574
Last synced: 2026-08-21
Market Cap
$105.17M
Change (1 day)
-0.75%
Change (1 year)
36.10%
Country
ID
Trade PT Merck Tbk (MERK)

Category

Number of shares outstanding for PT Merck Tbk (MERK)
Number of shares outstanding as of August 2026: 0
According to PT Merck Tbk latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for PT Merck Tbk (MERK) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors